Axon Enterprise, Inc. (NASDAQ:AXON) Receives Average Recommendation of “Buy” from Brokerages

Axon Enterprise, Inc. (NASDAQ:AXON) has received an average recommendation of “Buy” from the thirteen analysts that are covering the firm, Marketbeat.com reports. Thirteen equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $488.67.

AXON has been the subject of several recent research reports. JMP Securities raised their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Northland Securities raised their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Finally, Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th.

Axon Enterprise Trading Down 1.1 %

NASDAQ AXON opened at $604.32 on Tuesday. The firm has a 50 day simple moving average of $578.35 and a 200-day simple moving average of $430.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise has a one year low of $241.72 and a one year high of $698.67. The firm has a market cap of $46.08 billion, a price-to-earnings ratio of 156.16, a PEG ratio of 14.19 and a beta of 1.01.

Insider Activity

In related news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the transaction, the insider now directly owns 124,243 shares in the company, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 4,767 shares of Axon Enterprise stock in a transaction on Thursday, October 3rd. The shares were sold at an average price of $404.14, for a total transaction of $1,926,535.38. Following the completion of the transaction, the chief executive officer now owns 2,925,060 shares in the company, valued at approximately $1,182,133,748.40. This trade represents a 0.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 55,862 shares of company stock valued at $32,814,021 in the last ninety days. 6.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Axon Enterprise

Several institutional investors have recently made changes to their positions in the stock. Principal Financial Group Inc. boosted its position in shares of Axon Enterprise by 33.1% during the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after purchasing an additional 33,869 shares in the last quarter. Brass Tax Wealth Management Inc. purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth $240,000. Oddo BHF Asset Management Sas purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth $1,522,000. Denver PWM LLC boosted its position in shares of Axon Enterprise by 69.7% during the 3rd quarter. Denver PWM LLC now owns 414 shares of the biotechnology company’s stock worth $165,000 after purchasing an additional 170 shares in the last quarter. Finally, Tidal Investments LLC boosted its position in shares of Axon Enterprise by 13.8% during the 3rd quarter. Tidal Investments LLC now owns 3,250 shares of the biotechnology company’s stock worth $1,299,000 after purchasing an additional 394 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.